The positive effect of ALK inhibition in HCC in vitro was recently demonstrated by Yu et al. Two approved inhibitors crizotinib and ceritinib suppressed the proliferation of HCC cell lines and inhibited the ALK phosphorylation; moreover, ceritinib treatment induced cell apoptosis [19]. The gene discussed is ALK; the disease is hepatocellular carcinoma.